Mosapride citrate是促胃肠动力化合物,是5HT4激动剂。
Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Masahiro Tajika,et al. Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation. World J Gastroenterol. 2012 May 28; 18(20): 2517–2525. Published online 2012 May 28. doi: 10.3748/wjg.v18.i20.2517.
[2] In Su Jung,et al. Endoscopic Evaluation of Gastric Emptying and Effect of Mosapride Citrate on Gastric Emptying. Yonsei Med J. 2010 Jan 1; 51(1): 33–38. Published online 2009 Dec 29. doi: 10.3349/ymj.2010.51.1.33
[3] Qing Liu,et al. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: A systematic review. World J Gastroenterol. 2013 Dec 21; 19(47): 9111–9118. Published online 2013 Dec 21. doi: 10.3748/wjg.v19.i47.9111.
分子式 C27H37ClFN3O12 |
分子量 650.05 |
CAS号 112885-42-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 100 mM |
Water <1 mg/mL |
Ethanol 10 mM |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02201316 | Gastritis | Drug: Reference mosapride citrate (GASMOTIN)|Drug: GR107719B (Formulation 1)|Drug: GR107719B (Formulation 2) | GlaxoSmithKline | Phase 1 | 2014-02-01 | 2014-07-31 |
NCT02264587 | Diabetic Gastroparesis | Drug: Mosapride|Drug: domperidone | Liangzhou Wei|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.|Qingdao University | Phase 4 | 2014-10-01 | 2014-10-14 |
NCT02056405 | Postoperative Ileus | Drug: Mosapride|Drug: Placebo | Hospital Italiano de Buenos Aires | Phase 4 | 2015-12-01 | 2015-12-16 |
NCT01284764 | Foreign Body Left During Endoscopic Examination | Drug: Mosapride | Inje University | Phase 3 | 2011-01-01 | 2011-10-04 |
NCT02106130 | Healthy | Drug: Rebamipide|Drug: Mosapride citrate | IlDong Pharmaceutical Co Ltd | Phase 1 | 2013-05-01 | 2014-04-03 |
NCT00742872 | Constipation-Predominant Irritable Bowel Syndrome | Drug: Mosapride Citrate|Drug: Placebo | American University of Beirut Medical Center | Phase 3 | 2008-09-01 | 2013-02-27 |
NCT02180334 | Diabetes Mellitus, Type 2 | Drug: Mosapride citrate|Drug: Linagliptin|Drug: Acetaminophen (paracetamol) | Seoul National University Hospital|Daewoong Pharmaceutical Co. LTD. | Phase 4 | 2014-07-01 | 2014-06-30 |
NCT02433847 | Constipated Irritable Bowel Syndrome|Chronic Constipation|Healthy | Drug: Mosapride | Seoul National University Hospital | Phase 4 | 2015-05-01 | 2015-04-29 |
NCT00729339 | Gastroesophageal Reflux Disease | Drug: mosapride for the first month and placebo for the 2nd month|Drug: placebo for the first and mosapride for the second month | Lotung Poh-Ai Hospital|Tomorrow Medical Foundation | Phase 4 | 2008-06-01 | 2009-05-12 |
NCT01094847 | Bioequivalence | Drug: DWJ1252 | Daewoong Pharmaceutical Co. LTD. | Phase 1 | 2010-04-01 | 2011-05-19 |
NCT00663897 | Functional Dyspepsia|Epigastric Pain Syndrome|Post Prandial Distress Syndrome | Drug: lansoprazole|Drug: mosapride | Lotung Poh-Ai Hospital|Tomorrow Medical Foundation | Phase 4 | 2008-05-01 | 2009-10-08 |
NCT02606617 | Type 2 Diabetes | Drug: Mosapride|Drug: Placebo | Third Military Medical University | Phase 4 | 2015-12-01 | 2015-11-15 |
NCT02984930 | Gastroesophageal Reflux Disease | Drug: Administration of study drug (esomeprazole, mosapride)|Drug: Administration of study drug (esomeprazole, placebo tablet)|Procedure: upper endoscopy, scintigraphy | Gangnam Severance Hospital | 2016-12-01 | 2016-12-06 | |
NCT01505777 | Irritable Bowel Syndrome Without Diarrhea | Drug: Probiotics (Medirac)|Drug: Probiotics (Medirac)|Drug: Probiotics (Medirac)|Drug: Probiotics (Medirac)|Drug: Probiotics (Medirac) placebo/mosapride placebo | Hanmi Pharmaceutical Company Limited | Phase 2 | 2011-05-01 | 2013-04-04 |
NCT03040817 | Gastric Peroral Endoscopic Pyloromyotomy (G-POEM) | Procedure: Gastric peroral endoscopic pyloromyotomy (G-POEM)|Drug: Esomeprazole + Mosapride | Zhongda Hospital | 2017-02-16 | 2017-01-31 | |
NCT01411501 | Constipation | Other: acupuncture|Drug: mosapride citrate | Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Ministry of Science and Technology of the Peoples Republic of China | Phase 3 | 2011-09-01 | 2015-11-08 |
NCT01781897 | Functional Constipation | Device: acupuncture|Drug: mosapride | Huazhong University of Science and Technology | Phase 1 | 2013-02-01 | 2015-03-17 |
NCT01274793 | Functional Constipation|Functional Diarrhea | Drug: Mosapride Citrate tablet|Device: Low-dose acupuncture|Device: High-dose acupuncture | Huazhong University of Science and Technology|The Fifth Hospital of Wuhan|Wuhan Union Hospital, China|Guangzhou University of Traditional Chinese Medicine | Phase 1 | 2010-11-01 | 2015-03-17 |
NCT02831543 | Functional Dyspepsia | Drug: Motireb 5/100 mg|Drug: Mosapride citrate|Drug: Placebo | IlDong Pharmaceutical Co Ltd | Phase 3 | 2016-04-01 | 2016-07-11 |
NCT02887573 | Colorectal Polyps | Drug: Free-residue nutrients|Drug: Low fiber diet|Procedure: Colon capsule endoscopy|Drug: 2L PEG|Drug: 4L PEG|Drug: PEG|Drug: Mosapride citrate | Kaichun Wu|Xijing Hospital of Digestive Diseases | Phase 4 | 2014-01-01 | 2017-02-04 |
NCT02982668 | Severe Stroke|Acute Stroke|Dysphagia | Other: Initial enteral feeding|Drug: erythromycin | Xijing Hospital|Tang-Du Hospital|Xi'an Central Hospital|Shaanxi Provincial People's Hospital|Hanzhong Central Hospital|Yan'an University Affiliated Hospital | 2017-01-01 | 2016-12-13 | |
NCT01984931 | Nausea|Vomiting | Drug: Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)|Drug: Metoclopramide hydrochloride monohydrate | CM Chungmu Hospital|Korea United Pharm. Inc. | Phase 3 | 2013-10-01 | 2013-11-08 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们